Publications 2012

Ahmed-Lecheheb D, Cunat L, Hartemann P, Hautemanière A. Prospective observational study to assess hand skin condition after application of alcohol-based hand rub solutions. Am J Infect Control. 2012 Mar;40(2):160-4.

———————————————————————————————————————————————————

Ahmed-Lecheheb D, Cunat L, Hartemann P, Hautemanière A. Dermal and pulmonary absorption of ethanol from alcohol-based hand rub. J Hosp Infect. 2012 May;81(1):31-5.

———————————————————————————————————————————————————

Aide N, Visser EP, Lheureux S, Heutte N, Szanda I, Hicks RJ. The motivations and methodology for high-throughput PET imaging of small animals in cancer research. Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1497-509.

———————————————————————————————————————————————————

Albiges L, Oudard S, Negrier S, Caty A, Gravis G, Joly F, Duclos B, Geoffrois L, Rolland F, Guillot A, Laguerre B, Legouffe E, Kohser F, Dietrich Py, Theodore Ca, Escudier B. Complete remission with tyrosine kinase inhibitors in renal cell carcinoma. J Clin Oncol 2012;30(5):482-7.

———————————————————————————————————————————————————

Astoul P, Roca E, Galateau-Salle F, Scherpereel A. Malignant pleural mesothelioma: from the bench to the bedside. Respiration. 2012;83:481-93.

———————————————————————————————————————————————————

Audemard A, Boutemy J, Galateau-Salle F, Macro M, Bienvenu B. AL amyloidosis with temporal artery involvement simulates giant-cell arteritis. Joint Bone Spine. 2012 Mar;79(2):195-7.

———————————————————————————————————————————————————

Audemard A, Le Bellec ML, Carluer L, Dargère S, Verdon R, Castrale C, Lobbedez T, Hurault de Ligny B. Fumagillin-induced aseptic meningoencephalitis in a kidney transplant recipient with microsporidiosis. Transpl Infect Dis. 2012 Dec;14(6):E147-9.

———————————————————————————————————————————————————

Baldi I, Lebailly P, Rondeau V, Bouchart V, Blanc-Lapierre A, Bouvier G, Canal-Raffin M, Garrigou A. Levels and determinants of pesticide exposure in operators involved in treatment of vineyards: results of the PESTEXPO Study. J Expo Sci Environ Epidemiol. 2012;22(6):593-600.

———————————————————————————————————————————————————

Baret MC, Moutel G. [Clinical situation, resuscitation and ethics]. [Article in French] Rev Infirm. 2012 Dec;(186):51-2.

———————————————————————————————————————————————————

Bergot E, Creveuil C, Zalcman G. A STEPP too far for FLEX? Lancet Oncol. 2012 Feb;13(2):e51; author reply e51.

———————————————————————————————————————————————————

Bergot E, Haustraete E, Malbruny B, Magnier R, Salaün MA, Zalcman G. Observational study of QuantiFERON®-TB gold in-tube assay in tuberculosis contacts in a low incidence area. PLoS One. 2012;7(8):e43520.

———————————————————————————————————————————————————

Borget I, Cadranel J, Pignon JP, Quoix E, Coudert B, Westeel V, Dansin E, Madelaine J, Madroszyk A, Friard S, Daniel C, Morin F, Chouaid C; ERMETIC Collaborative Group. Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3. Eur Respir J. 2012 Jan;39(1):172-9.

———————————————————————————————————————————————————

Borel M, Veber B, Hervé C, Rigaud JP, Moutel G, Rey N, Dureuil B. [Conditions of decision making of admission or non-admission in surgical intensive care unit]. [Article in French] Ann Fr Anesth Reanim. 2012 Mar;31(3):203-7.

———————————————————————————————————————————————————

Bridoux V, Moutel G, Roman H, Kianifard B, Michot F, Herve C, Tuech JJ. Methodological and ethical quality of randomized controlled clinical trials in gastrointestinal surgery. J Gastrointest Surg. 2012 Sep;16(9):1758-67.

———————————————————————————————————————————————————

Bridoux V, Schwarz L, Kianifard B, Moutel G, Herve C, Tuech JJ. Systematic review and meta-analysis of randomized clinical trials of self-expanding metallic stents as a bridge to surgery versus emergency surgery for malignant left-sided large bowel obstruction (Br J Surg 2012; 99: 469-476). Br J Surg. 2012 Oct;99(10):1464; author reply 1464-5.

———————————————————————————————————————————————————

Cadranel J, Mauguen A, Faller M, Zalcman G, Buisine MP, Westeel V, Longchampt E, Wislez M, Coudert B, Daniel C, Chetaille B, Michiels S, Blons H, Solassol J, De Fraipont F, Foucher P, Urban T, Lacroix L, Poulot V, Quoix E, Antoine M, Danton G, Morin F, Chouaid C, Pignon JP. Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project–part 2). J Thorac Oncol. 2012Oct;7(10):1490-502.

———————————————————————————————————————————————————

Chamming’s S, Clin B, Brochard P, Astoul P, Ducamp S, Galateau-Sallé F, Gilg Soit Ilg A, Goldberg M, Imbernon E, Rolland P, Pairon JC. Compensation of pleural mesothelioma in France: date from the French national mesothelioma surveillance programme. Am J Ind Med 2012;56(2):146-154.*Both authors contributed equally to this work.

———————————————————————————————————————————————————

Churg A, Galateau-Salle F. The separation of benign and malignant mesothelial proliferations. Arch Pathol Lab Med. 2012 Oct;136(10):1217-26.

———————————————————————————————————————————————————

Ciappuccini R, Trzepla G, Heutte N, Sevin E, Galais MP, Bardet S. Sorafenib increases18-FDG colic uptake: demonstration in patients with differentiated thyroid cancer. EJNMMI Res. 2012; 2 :18.

———————————————————————————————————————————————————

Ciappuccini R, Morera J, Pascal P, Rame JP, Heutte N, Aide N, Babin E, Reznik Y, Bardet S. Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experience. Clin Nucl Med.2012 Mar;37(3):223-8.

———————————————————————————————————————————————————

Clin B, Andujar P, Abd Al Samad I, Azpitarte C, Lepimpec-Barthes F, Billon-Galland MA, Danel C, Galateau-Salle F, Housset B, Legrand-Cattan K, Matrat M, Monnet I, Riquet M, Pairon JC. Pulmonary carcinoid tumors and exposure to asbestos. Ann Occup Hyg 2012;56(7):789-95.

———————————————————————————————————————————————————

Colombo N, Kutarska E, Dimopoulos M, Bae Ds, Rzepka-Gorska I, Bidzinski M, Scambia G, Engelholm Sa, Joly F, Weber D, El-Hashimy M, Li J, Souami F, Wing P, Engelholm S, Bamias A, Schwartz P. Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer. J Clin Oncol 2012;30(31):3841-7.

———————————————————————————————————————————————————

Coquan E, Henri P, De Raucourt S, Lireux B, Lamy E, Delcambre C, Sevin E, Dutriaux C, Bouhier-Leporrier K, Gervais R, Joly F. Principes de prise en charge des effets indésirables des thérapies ciblées en cancérologie. Rev Prat 2012;62(1):17-25.

———————————————————————————————————————————————————

Corvol A, Moutel G, Somme D. [Case management in gerontology: new practice, new issue]. [Article in French] Med Sci (Paris). 2012 Mar;28(3):321-4.

———————————————————————————————————————————————————

Couraud S, Cortot AB, Greillier L, Gounant V, Mennecier B, Girard N, Besse B, Brouchet L, Castelnau O, Frappé P, Ferretti GR, Guittet L, Khalil A, Lefebure P, Laurent F, Liebart S, Molinier O, Quoix E, Revel MP, Stach B, Souquet PJ, Thomas P, Trédaniel J, Lemarié E, Zalcman G, Barlési F, Milleron B; on behalf of the French lung cancer screening statement taskforce. From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d’Oncologie de langue francaise (GOLF). Ann Oncol. 2012 Nov 7. [Epub ahead of print] PubMed PMID: 23136229.

———————————————————————————————————————————————————

Couraud S, Zalcman G, Milleron B, Morin F, Souquet PJ. Lung cancer in never smokers–a review. Eur J Cancer. 2012 Jun;48(9):1299-311.

———————————————————————————————————————————————————

Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J, Weber DC, Ricardi U, Slowinski J, Brandes A; RARECARE working group. Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer. 2012 Jul;48(10):1532-42. Epub 2012 Jan 7.

———————————————————————————————————————————————————

de Fraipont F, Levallet G, Creveuil C, Bergot E, Beau-Faller M, Mounawar M, Richard N, Antoine M, Rouquette I, Favrot MC, Debieuvre D, Braun D, Westeel V, Quoix E, Brambilla E, Hainaut P, Moro-Sibilot D, Morin F, Milleron B, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique. An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial. Clin Cancer Res. 2012 May 15;18(10):2976-86

———————————————————————————————————————————————————

Dejardin O, Ruault E, Jooste V, Pornet C, Bouvier V, Bouvier AM, Launoy G. Volume of surgical activity and lymph nodes evaluation for patients with colorectal cancer in France. Digestive and Liver Disease 2012 Mar;44(3):261-7.

———————————————————————————————————————————————————

Edern A, Fines-Guyon M, Castrale C, Ficheux M, Ryckelynck JP, Lobbedez T. [Ecology and mechanisms of bacterial resistance to antibiotics in peritonitis]. [Article in French] Nephrol Ther. 2012 Nov;8(6):456-61.

———————————————————————————————————————————————————

Euvrard S, Morelon E, Rostaing L, Goffin E, Brocard A, Tromme I, Broeders N, del Marmol V, Chatelet V, Dompmartin A, Kessler M, Serra AL, Hofbauer GF, Pouteil-Noble C, Campistol JM, Kanitakis J, Roux AS, Decullier E, Dantal J; TUMORAPA Study Group. Sirolimus and secondary skin-cancer prevention in kidney transplantation. N Engl J Med. 2012 Jul 26;367(4):329-39.

———————————————————————————————————————————————————

Evans D, Chaix B, Lobbedez T, Verger C, Flahault A. Combining directed acyclic graphs and the change-in-estimate procedure as a novel approach to adjustment-variable selection in epidemiology. BMC Med Res Methodol. 2012 Oct 11;12:156.

———————————————————————————————————————————————————

Enel C, Matte A, Berchi C, Binquet C, Cormier L, Lejeune C. Traitement du cancer de la prostate : quel choix pour les patients. Bulletin du Cancer.

———————————————————————————————————————————————————

Gatta G, Ferrari A, Stiller CA, Pastore G, Bisogno G, Trama A, Capocaccia R; RARECARE Working Group. Embryonal cancers in Europe. Eur J Cancer. 2012 Jul;48(10):1425-33.

———————————————————————————————————————————————————

Gentil J, Dabakuyo T, Ouedraogo S, Poillot ML, Dejardin O and Arveux P. For patients with breast cancer, geographic and social disparities are independent determinants of access to specialized surgeons. A eleven-year population-based multilevel analysis. BMC Cancer 2012 12:351.

———————————————————————————————————————————————————

Gramond C, Rolland P, Lacourt A, Ducamp S, Chamming’s S, Creau Y, Hery M, Laureillard J, Mohammed-Brahim B, Orlowski E, Paris C, Pairon JC, Goldberg M, Brochard P; PNSM Study Group. Choice of rating method for assessing occupational asbestos exposure: study for compensation purposes in France. Am J Ind Med. 2012 May;55(5):440-9.

———————————————————————————————————————————————————

Guillois B, Castel S, Beunard A, Blaizot X, Creveuil C, Proia-Lelouey N. [Effect of early intervention programs on neurobehavioral outcome in premature infants after discharge]. [Article in French] Arch Pediatr. 2012 Sep;19(9):990-7.

———————————————————————————————————————————————————

Guittet L, Bouvier V, Guillaume E, Levillain R, Ruiz A, Lantieri O, Launoy G. Colorectal cancer screening: why immunochemical faecal occult blood test performs as well with either one or two samples. Dig Liver Dis. 2012;44:694-9.

———————————————————————————————————————————————————

Halloran S, Launoy G, Zappa M. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition. Fecal occult blood testing. Endoscopy 2012;44:1-23.

———————————————————————————————————————————————————

Hamon M, Lipiecki J, Carrié D, Burzotta F, Durel N, Coutance G, Boudou N, Colosimo C, Trani C, Dumonteil N, Morello R, Viader F, Claise B, Hamon M. Silent cerebral infarcts after cardiac catheterization: a randomized comparison of radial and femoral approaches. Am Heart J. 2012 Oct;164(4):449-454.e1.

———————————————————————————————————————————————————

Heyndrickx M, Ivascau C, Galateau-Sallé F, Massetti M. Aortic fibroelastoma and 3-dimensional computed tomography scan volume rendering: a fair reflection of reality? Eur J Cardiothorac Surg. 2012 Oct;42(4):752-3.

———————————————————————————————————————————————————

Heyndrickx M, Galateau-Salle F, Herry I, Icard P. Pulmonary botryomycosis on a lung cavity: a rare pulmonary infection mimicking cancer. Gen Thorac Cardiovasc Surg. 2012 Sep;60(9):607-9.

———————————————————————————————————————————————————

Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson A, Roggli V, Travis WD, Wick M. Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2012 Aug 28.

———————————————————————————————————————————————————

Jean D, Daubriac J, Le Pimpec-Barthes F, Galateau-Sallé F, Jaurand MC. Molecular changes in mesothelioma with an impact on prognosis and treatment. Arch Pathol Lab Med. 2012; 136:277-93.

———————————————————————————————————————————————————

Joly F, Lange M, Rigal O, Correia H, Giffard B, Beaumont Jl, Clisant S, Wagner L. French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3. Support Care Cancer 2012;20(12):3297-305.

———————————————————————————————————————————————————

Kostianovsky A, Hauser T, Pagnoux C, Cohen P, Daugas E, Mouthon L, Miossec P, Cordier JF, Guillevin L; French Vasculitis Study Group (FVSG). Alveolar haemorrhage in ANCA-associated vasculitides: 80 patients’ features and prognostic factors. Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S77-82.

———————————————————————————————————————————————————

Kuhn-Beck F, Moutel G, Weingertner AS, Kohler M, Hornecker F, Hunsinger MC, Kohler A, Mager C, Neumann M, Nisand I, Favre R. Fetal reduction of triplet pregnancy: one or two? Prenat Diagn. 2012 Feb;32(2):122-6.

———————————————————————————————————————————————————

Jooste V, Grosclaude P, Remontet L, Launoy G, Baldi I, Molinié F, Arveux  P, Bossard N, Bouvier AM, Colonna M. Unbiased estimates of long-term net survival of solid  cancers in France. International Journal of Cancer 2012 Sep 24.

———————————————————————————————————————————————————

Kurtz Je, Freyer G, Joly F, Gladieff L, Kaminski Mc, Fabbro M, Floquet A, Hardy-Bessard Ac, Raban N, Ray-Coquard I, Pujade-Lauraine E. Combined Oral Topotecan Plus Carboplatin In Relapsed Or Advanced Cervical Cancer: A Gineco Phase I-Ii Trial. Anticancer Res 2012;32(3):1045-9

———————————————————————————————————————————————————

Lanier C, Andre V, Seguin V, Heutte N, El Kaddoumi A, Bouchart V, Picquet R, Garon D. Recurrence of Stachybotrys chartarum during mycological and toxicological study of bioaerosols collected in a dairy cattle shed. Ann Agric Environ Med. 2012; 19(1) :61-7.

———————————————————————————————————————————————————

Lasnon C, Hicks RJ, Beauregard JM, Milner A, Paciencia M, Guizard AV, Bardet S, Gervais R, Lemoel G, Zalcman G, Aide N. Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer. Clin Nucl Med. 2012 Oct;37(10):971-6.

———————————————————————————————————————————————————

Launay L, Dejardin O, Pornet C, Morlais F, Guittet L, Launoy G, Bouvier V. Influence of socioeconomic environment on survival in patients diagnosed with esophageal cancer: a population-based study. Dis Esophagus. 2012;25:723-30.

———————————————————————————————————————————————————

Leclercq C, Bouchot O, Azzouzi Ar, Joly F, Miaadi N, Pfister C, Vincendeau S, De Crevoisier R. Hormonothérapie Et Risque Cardiaque Dans Le Traitement Des Cancers Prostatiques. Prog Urol 2012;22 Suppl 2:S48-S54.

———————————————————————————————————————————————————

Le Hello C, Morello R, Fradin S, Coffin O, Maïza D, Hamon M. Beware of suboptimal medical management of patients with atherosclerosis requiring revascularization. Int Angiol. 2012 Jun;31(3):260-70.

———————————————————————————————————————————————————

Levallet G, Bergot E, Antoine M, Creveuil C, Santos AO, Beau-Faller M, de Fraipont F, Brambilla E, Levallet J, Morin F, Westeel V, Wislez M, Quoix E, Debieuvre D, Dubois F, Rouquette I, Pujol JL, Moro-Sibilot D, Camonis J, Zalcman G; Intergroupe Francophone de Cancérologie Thoracique (IFCT). High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway. Mol Cancer Ther. 2012 May;11(5):1203-13.

———————————————————————————————————————————————————

Levallet G, Vaisse-Lesteven M, Le Stang N, Ilg AG, Brochard P, Astoul P, Pairon JC, Bergot E, Zalcman G, Galateau-Sallé F. Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH Group. J Thorac Oncol. 2012; 7:599-606.

———————————————————————————————————————————————————

Letourneux M, Clin B, Marquignon MF, Gauberti P. [What tools should be used for follow-up post occupational exposure? What should be the frequency?]. Rev Mal Respir. 2012 Feb;29(2):205-12.

———————————————————————————————————————————————————

Lheureux S, Joly F. [Cabazitaxel after docetaxel: a new option in metastatic castration-resistant prostate cancer]. [Article in French] Bull Cancer. 2012 Sep;99(9):875-80.

———————————————————————————————————————————————————

Lheureux S1, Joly F. [Endometrial cancer: place for adjuvant chemotherapy]. [Article in French] Bull Cancer. 2012 Jan;99(1):85-91.

———————————————————————————————————————————————————

Lheureux S, Krieger S, Weber B, Pautier P, Fabbro M, Selle F, Bourgeois H, Petit T, Lortholary A, Plantade A, Briand M, Leconte A, Richard N, Vilquin P, Clarisse B, Blanc-Fournier C, Joly F. Expected Benefits of Topotecan Combined With Lapatinib in Recurrent Ovarian Cancer According to Biological Profile: A Phase 2 Trial. Int J Gynecol Cancer 2012;22(9):1483-8.

———————————————————————————————————————————————————

Ligier K, Plouvier S, Danzon A, Martin P, Benoît E, Molinié F, Launoy G, Buisset E, Leroy X, Chevalier D, Chaud P, Chérié-Challine L. Elements of completeness and results of the first year of registration of the « Registre général des cancers de Lille et de sa région. Rev Epidemiol Sante Publique. 2012 Apr;60(2):131-9.

———————————————————————————————————————————————————

Lobbedez T, Boissinot L, Ficheux M, Castrale C, Ryckelynck JP. How to avoid technique failure in peritoneal dialysis patients? Contrib Nephrol. 2012;178:53-7.

———————————————————————————————————————————————————

Lobbedez T, Verger C, Ryckelynck JP, Fabre E, Evans D. Is assisted peritoneal dialysis associated with technique survival when competing events are considered? Clin J Am Soc Nephrol. 2012 Apr;7(4):612-8.

———————————————————————————————————————————————————

Meijnders P, Carde P, Girinsky T, Kluin-Nelemans JC, Henry-Amar M, Raemaekers JMM, Karrasch M, van der Maazen R, for the EORTC Lymphoma Group. Clinical achievements of the EORTC Lympohma group and aspects of future strategy. Eur J Cancer 2012;10(Suppl 1):105-111.

———————————————————————————————————————————————————

Monnereau A, Troussard X, Belot A, Guizard AV, Woronoff AS, Bara S, Lapôtre-Ledoux B, Iwaz J, Tretarre B, Maynadié M; The French Network of Cancer Registries (FRANCIM). Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France. Int J Cancer. 2012 Oct 3.

———————————————————————————————————————————————————

Montani D, Bergot E, Günther S, Savale L, Bergeron A, Bourdin A, Bouvaist H, Canuet M, Pison C, Macro M, Poubeau P, Girerd B, Natali D, Guignabert C, Perros F, O’Callaghan DS, Jaïs X, Tubert-Bitter P, Zalcman G, Sitbon O, Simonneau G, Humbert M. Pulmonary arterial hypertension in patients treated by dasatinib. Circulation. 2012 May 1;125(17):2128-37.

———————————————————————————————————————————————————

Mouadil A, Debout C, Read MH, Morello R, Allouche S, Chapon F. Blood metabolite data in response to maximal exercise in healthy subjects. Clin Physiol Funct Imaging. 2012 Jul;32(4):274-81.

———————————————————————————————————————————————————

Mouillet G, Monnet E, Milleron B, Puyraveau M, Quoix E, David P, Ducoloné A, Molinier O, Zalcman G, Depierre A, Westeel V; Intergroupe Francophone de Cancérologie Thoracique (IFCT). Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials. J Thorac Oncol. 2012 May;7(5):841-9.

———————————————————————————————————————————————————

Mounier N, Heutte N, Thieblemont C, Briere J, Gaulard P, Feugier P, Ghesquieres H, Van Den Neste E, Robu D, Tilly H, Bouabdallah R, Safar V, Coiffier B; Groupe d’Etude des Lymphomes de l’Adulte (GELA).Ten-Year Relative Survival and Causes of Death in Elderly Patients Treated With R CHOP or CHOP in the GELA LNH-985 Trial. Clin Lymphoma Myeloma Leuk. 2012; 12(3) :151-4.

———————————————————————————————————————————————————

Mouriaux F, Diorio C, Bergeron D, Berchi C, Rousseau A. Liver function testing is not helpful for early diagnosis of metastatic uveal melanoma. Ophthalmology 2012; 119(8) : 1590-5.

———————————————————————————————————————————————————

Mouriaux F, Rysanek B, Babin E, Cattoir V. [Orbital cellulitis]. J Fr Ophtalmol. 2012 Jan;35(1):52-7.

———————————————————————————————————————————————————

Moutel G. [Why patient consent is not to be neglected?]. [Article in French] Gynecol Obstet Fertil. 2012 Nov;40(11):698-700.

———————————————————————————————————————————————————

Mutinelli-Szymanski P, Caille A, Tranquart F, Al-Najjar A, Büchler M, Barbet C, Marlière JF, Gatault P, Réault J, Boin C, Chatelet V, Laouad I, Nivet H, Lebranchu Y, Halimi JM. Renal resistive index as a new independent risk factor for new-onset diabetes mellitus after kidney transplantation. Transpl Int. 2012 Apr;25(4):464-70.

———————————————————————————————————————————————————

Oberaigner W, Minicozzi P, Bielska-Lasota M, Allemani C, de Angelis R, Mangone L, Sant M; Eurocare Working Group. Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade. Acta Oncol. 2012 Apr;51(4):441-53.

———————————————————————————————————————————————————

Opletalová K, Blaizot X, Mourgeon B, Chêne Y, Creveuil C, Combemale P, Laplaud AL, Sohyer-Lebreuilly I, Dompmartin A. Maggot therapy for wound debridement: a randomized multicenter trial. Arch Dermatol. 2012 Apr;148(4):432-8.

———————————————————————————————————————————————————

Orgerie MB, Duchange N, Pélicier N, Rosset P, Lemarié E, Dorval E, Chapet S, Hervé C, Moutel G. [Multidisciplinary meetings in oncology do not impact the physician-patient relationship]. [Article in French] Presse Med. 2012 Mar;41(3 Pt 1):e87-94.

———————————————————————————————————————————————————

Pérol M, Chouaid C, Pérol D, Barlési F, Gervais R, Westeel V, Crequit J, Léna H, Vergnenègre A, Zalcman G, Monnet I, Le Caer H, Fournel P, Falchero L, Poudenx M, Vaylet F, Ségura-Ferlay C, Devouassoux-Shisheboran M, Taron M, Milleron B. Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation, with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol. 2012 Oct 1;30(28):3516-24.

———————————————————————————————————————————————————

Pornet C, Delpierre C, Dejardin O, Grosclaude P, Launay L, Guittet L, Lang T, Launoy G. Construction of an adaptable European transnational ecological deprivation index: the French version Journal of Epidemiology and community Health . 2012 Nov;66(11):982-9.

———————————————————————————————————————————————————

Prevost V, Grach MC. Nutritional support and quality of life in cancer patients undergoing palliative care. Eur J Cancer Care (Engl). 2012 Sep;21(5):581-90.

———————————————————————————————————————————————————

Quenot JP, Rigaud JP, Prin S, Barbar S, Pavon A, Hamet M, Jacquiot N, Blettery B, Hervé C, Charles PE, Moutel G. Suffering among carers working in critical care can be reduced by an intensive communication strategy on end-of-life practices. Intensive Care Med. 2012 Jan;38(1):55-61.

———————————————————————————————————————————————————

Quenot JP, Rigaud JP, Prin S, Barbar S, Pavon A, Hamet M, Jacquiot N, Blettery B, Hervé C, Charles PE, Moutel G. Impact of an intensive communication strategy on end-of-life practices in the intensive care unit. Intensive Care Med. 2012 Jan;38(1):145-52.

———————————————————————————————————————————————————

Ray-Coquard I, Chauvin F, Leblanc E, Caux C, Hoarau H, Bonnetain F, Christophe V, Sastre-Garau X, Lazennec G, Poulain L, Haie-Meder C, Pujade-Lauraine E, Salzet M, Deutsch E, Devouassoux M, Penault Llorca F, Lecuru F, Taieb S, Arveux P, Theillet C, Joly F. [PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved]. [Article in French] Bull Cancer. 2012 Apr 1;99(4):479-98.

———————————————————————————————————————————————————

Reinbold D, Eboue C, Morello R, Lamendour N, Herlicoviez M, Dreyfus M. [From the impact of French guidelines to reduce episiotomy's rate]. J Gynecol Obstet Biol Reprod (Paris). 2012 Feb;41(1):62-8.

———————————————————————————————————————————————————

Rognant S, Benoist G, Creveuil C, Dreyfus M. Obstetrical situations with a high risk of anal sphincter laceration in vacuum-assisted deliveries. Acta Obstet Gynecol Scand. 2012 Jul;91(7):862-8.

———————————————————————————————————————————————————

Ryckelynck JP, Ficheux M, Castrale C, Henri P, Lobbedez T. Adequacy in peritoneal dialysis. Contrib Nephrol. 2012;178:195-9.

———————————————————————————————————————————————————

Sant M, Minicozzi P, Lagorio S, Børge Johannesen T, Marcos-Gragera R, Francisci S; EUROCARE Working Group. Survival of European patients with central nervous system tumors. Int J Cancer. 2012 Jul 1;131(1):173-85.

———————————————————————————————————————————————————

Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012 Dec 20;367(25):2407-18.

———————————————————————————————————————————————————

Van der Kaaij MAE, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Simons AHM, Lugtenburg PJ, Aleman BMP, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Bologna S, Ong F, Eghbali H, Doorduijn JK, Morschhauser F, Sebban C, Roesink JM, Bouteloup M, van Hoof A, Raemaekers JMM, Henry-Amar M, Kluin-Nelemans HC. Premature ovarian failure and fertility in long-term survivors of Hodgkin lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d’Étude des Lymphomes de l’Adulte cohort study. J Clin Oncol 2012;30(3):291-299.

———————————————————————————————————————————————————

Van der Kaaij MAE, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Dubois B, Simons AHM, Lugtenburg PJ, Aleman BMP, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Eghbali H, Gaillard I, Doorduijn JK, Sebban C, Smit WGJM, Bologna S, Roesink JM, Ong F, André M, Raemaekers JMM, Henry-Amar M, Kluin-Nelemans HC. Parenthood in survivors of Hodgkin Lymphoma: An EORTC-GELA General Population Case-Control Study. J Clin Oncol. 2012; 30(31):3854-63.